Compare Abbott Laboratories (ABT) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Occidental Petroleum Corporation — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while Occidental Petroleum Corporation trades at $53.6 (market cap $51.40B). The key difference: Abbott Laboratories is far larger — about 3.2× Occidental Petroleum Corporation's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | OXY | |
|---|---|---|
Market Cap | $166.94B | $51.40B |
Sector | Health | Energy |
52-Week High | $136.62 | $66.24 |
52-Week Low | $82.57 | $38.92 |
Enterprise Value | $193.69B | $72.49B |
Dividend Yield | 2.63% | 2.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Occidental Petroleum (OXY) trades at $51.68, up 5.66% with strong recent earnings beats. The stock shows bearish technical signals but attractive valuation with EV/EBITDA of 6.34x. Recent CEO transition and debt reduction efforts are key developments, while oil price volatility remains a primary factor. Analyst consensus leans positive with 48% buy ratings and $66.86 price target suggesting 29% upside potential from current levels.
OXY presents value opportunity with reasonable valuation and consistent earnings outperformance, though exposure to oil prices and execution risks under new leadership warrant caution. The company's pivot toward carbon capture technologies and Permian Basin strength provide long-term growth catalysts, but near-term performance depends on commodity price stability and successful debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
